药品首页 >
产品预订 > 稀缺预定

Suglat 伊格列净/L-脯氨酸

通用名称伊格列净/L-脯氨酸 Ipragliflozin / L-proline
品牌名称Suglat
产地|公司日本(Japan) | 安斯泰来(Astellas)
技术状态原研产品
成分|含量50mg
包装|存储100片/盒 室温
微信客服
Xirou_Canada
微信ID
(8:00-15:00)
服务时间
通用中文 伊格列净/L-脯氨酸 通用外文 Ipragliflozin / L-proline
品牌中文 品牌外文 Suglat
其他名称
公司 安斯泰来(Astellas) 产地 日本(Japan)
含量 50mg 包装 100片/盒
剂型给药 片剂 口服 储存 室温
适用范围 二型糖尿病
通用中文 伊格列净/L-脯氨酸
通用外文 Ipragliflozin / L-proline
品牌中文
品牌外文 Suglat
其他名称
公司 安斯泰来(Astellas)
产地 日本(Japan)
含量 50mg
包装 100片/盒
剂型给药 片剂 口服
储存 室温
适用范围 二型糖尿病

使用说明书

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)
等待内容更新

中文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)

Astellas Pharma公司的Suglat(伊格列净/L-脯氨酸,ipragliflozin L-proline)25和50mg片剂治疗2型糖尿病在日本获得上市许可证。该公司于2013年3月申报此批准。

 

伊格列净/L-脯氨酸属于选择性钠/钠-葡萄糖转运蛋白质类2(SGLT2)抑制剂,是与Kotobuki Pharmaceutical公司通过科研合作发现和开发的。该药通过选择性抑SGLT2而抑制葡萄糖再摄取,从而降低血糖。

 

伊格列净 L-脯氨酸单药治疗的一项III期关键性试验,以及该药与其他降糖药联用的多项临床研究,支持了本品在日本的获批。Astellas公司将制造和销售产品,并与Kotobuki Pharmaceutical和MSD K.K.两家公司共同推广.

外文说明

(免责声明:本说明书仅供参考,不作为治疗的依据,不可取代任何医生、药剂师等专业性的指导。本站不提供治疗建议,药物是否适合您,请专业医生(或药剂师)决定。)
 Description

This medicine inhibits SGLT2 which resorbs glucose in the kidney, thus reducing blood glucose through the excretion of excess glucose into urine.
It is usually used for the treatment of type 2 diabetes.

PresentationFeatureActive Ingredients

Ipragliflozin L-Proline

Effect/EfficacyUsage/Dosage

In general, for adults, take 1 tablet (50 mg of ipragliflozin) at a time, once a day before or after breakfast. If the effect of this medicine is insufficient, it may be increased up to 2 tablets (100 mg) once a day while carefully following the course of the disease. If you have a severe hepatic impairment, the dosage may be started with low doses. Strictly follow the instructions.
If you miss a dose, skip the missed dose and continue your regular dosing schedule. You should never take two doses at one time.
If you accidentally take more than your prescribed dose, consult with your doctor or pharmacist.
Do not stop taking this medicine unless your doctor instructs you to do so.

Cautions

Strictly follow the instructions on dietary/exercise therapy.
This medicine may cause hypoglycemic symptoms. Be aware of operating in potentially hazardous activities such as driving a car and working at heights.
Take foods containing sugar or drink juice if any hypoglycemic symptoms occur. If you are taking in conjunction with α-glucosidase inhibitors (medicines which delay the uptake of glucose) and hypoglycemic symptoms develop, you must take in glucose.
Take a larger amount of water, since this medicine may cause dehydration. Intake of water or tea is desirable, since drink including sugar such as isotonic drink may increase blood glucose.
Do not stop taking water or decrease the amount of water on your own judgment.
Stop taking the medicine if you have repeated diarrhea/vomiting or cannot take food or water continuously due to decreased appetite.

Possible adverse reactions to this medicine
The most commonly reported adverse reactions include urinary frequency, thirst, constipation, and weight loss. If any of these symptoms occur, consult with your doctor or pharmacist.
The symptoms described below are rarely seen as initial symptoms of the adverse reactions indicated in brackets. If any of these symptoms occur, stop taking this medicine and see your doctor immediately.
light headedness, lassitude, sweating, hunger, shaking of hands and feet [hypoglycemia]
chills, fever, flank pain, back pain, lower back pain [pyelonephritis]
Thirst/dry mouth, large urinary volume, dizziness/lightheadedness [dehydration]
The above symptoms do not describe all the adverse reactions to this medicine. Consult with your doctor or pharmacist if you notice any symptoms of concern other than those listed above.